Notre actualité
Vaihere Cheung obtained her technology baccalaureate in Sciences and Laboratory Techniques (STL) in 2018 at La Mennais, in French Polynesia. Afterwards, she came to Metropolitan France to pursue her studies in biological engineering at the Technological Institute in Lyon University. In this context, she performed an internship in two laboratories Read more…
Among 370 applications from 54 countries, I am proud to be selected with 9 other start-ups for Female Founder Challenge organized by Vivatechnology & 50inTech. We are to women frmn France. “In Europe, 92% of the funds were invested in startups founded by men. The tech sector needs to be Read more…
Stage assistant ingénieur (~ niveau m1) prévu du 1er septembre 2020 au 12 février 2021 (6 mois) La société HCS Pharma (Loos, France) recherche un stagiaire de master 1 pour fin 2020. La personne recrutée travaillera sur un projet R&D de technologie innovante de type « Organe sur Puce » pour l’oncologie. Read more…
As we are involved in some very interesting projects, we have the chance to work with amazing specialists in many field. All these people help us to make the BIOMIMESYS® technology better, easier to use and well adapted to their work. We asked them to explain why they use BIOMIMESYS® Read more…
Dear all, We hope this email finds you, your family and colleagues well! We are available to discuss with you:– about your needs in high content screening/analysis services. We would be happy to organise videoconferences and phone calls to see how imaging can foster your R&D, by testing the safety Read more…
Our BIOMIMESYS® products are now available in the Dominique Dutscher’s catalogue. We are very happy to work with such a famous company ! Founded in 1982 in Alsace (France) Dominique Dutscher SAS is specialized in the distribution of laboratory consumables and equipment for research, biotechnology and health. We share with Read more…
Immersive technologies (XR) are playing an increasingly important role in many areas of the healthcare sector. In HCS Pharma we monitor this progress and we have used these technologies many times, for example at the installation of our robotic platform. Then we were very happy when Laval Virtual, one of Read more…
Elisa Moya started her bachelor’s degree in 2013, in Biological Sciences, at the University of Granada, Spain. During her career period, in 2015, she studied one year in Portugal (Erasmus+). Moreover, in the summer 2016, she participated during 3 months in a research project dealing with Alzheimer’s disease in Newcastle Read more…
Dr. Karine Hannebicque has joined our Scientific Advisory Board. She is a surgeon in breast cancer and reconstructive surgery working in Oscar Lambret Center in the Department of breast oncology since 2013. She is also Medical Coordinator of the Ambulatory Surgery Unit since 2018. After her Internship in Obstetrics & Read more…
We are really happy to welcome Prof. Lo in our Scientific Advisory Board. Prof. Lo has a huge experiment in hepatitis infection and liver diseases with more than 120 publications in this field. With help of Joseph Chou (CEO of Tokyo Future Style Taiwan), Pr Lo leads all R&D programs Read more…
As part of the validation of her Master’s degree in biotechnology (University of Lille), specializing in cellular and molecular engineering, Elise recently joined HCS Pharma. After having completed three internships from one to four months in the fields of immunology and microbiology, in France and abroad, she joined the team Read more…
Just before Covid-19 pandemic crisis widely spread to France, we attended the User Meeting organized by Molecular Devices in Hilton Garden Inn Leiden (Oegstgeest, Netherlands). We enjoyed the programme, gathering a variety of topics but with high content analysis/screening as a common technique to answer diverse scientific questions. On the Read more…
As many companies in France and in the world, the COVID-19 pandemic deeply affects our activities. For safety reasons, most of our work is now done remotely but we maintain essential activity in laboratories to take care of our cells and try to finish our ongoing customer studies. The situation Read more…
Présentation de l’entreprise HCS Pharma est une start-up biotechnologique spécialisée en imagerie cellulaire pour le criblage et l’étude de l’efficacité ou la toxicité de molécules d’intérêt pharmaceutique, cosmétique ou agroalimentaire. Nous développons pour cela nos propres modèles in vitro, en 2 et 3 dimensions, grâce à la technologie BIOMIMESYS®, qui Read more…
We will give a presentation next week (on Tuesday, 10th of March 2020) at the High-Content Cellular Imaging User meeting organized by our partner Molecular Devices, which will take place in Leiden (Netherlands). It is a great pleasure for us to attend the meeting, and to talk about the applications, Read more…
It was a real pleasure for us to be invited at the last West Data Festival, to present our last developments in Artificial Intelligence dedicated to picture analysis. We warmly thank the organizers, Laval Mayenne Technopole and ATLANPOLE biotérapies for this opportunity. We also thank Laval Virtual to help us Read more…
We are happy to tell you that HCS Pharma, SMMiL-E team (Seeding Microsystems in Medecine in Lille – European-Japanese Technologies against Cancer, CNRS UMI-2820 LIMMS/IIS) and Institut d’Electronique, de Micro-Electronique et de Nanotechnologie (IEMN) have successfully applied to a LabCom grant (‘COMmon LABoratory’)! A LabCom aims at gathering two entities Read more…
We often talk about our innovative product BIOMIMESYS® here to explain how we (and others!) us it in many cases. You can imagine that 3D cell culture with this product is complicated or that you have to spend a lot of time in training. But it’s actually quite simple to Read more…
It will a short article today to wish you a wonderful Christmas and all our best wish for this new year! We don’t known how will be 2020 but we are optimistic : We will work to cure complex diseases like cancers, we will explore new food production for a Read more…
Biomimesys is providing a great opportunity to culture human induced pluripotent stem cells (hiPSCs) in 3D and differentiate them into different kind of cell types including liver cells. Showcased by Méryl Roudaut at the 20th International Congress on In Vitro Toxicology (ESTIV2018), our co-development with the institute du thorax (U1087) Read more…
Nathalie and Elodie were in Marseille last week for BioFit event, where we had a booth under Clubster NHL (Nutrition-Health-Longevity) Pavilion: We would like to thank all the participants and collaborators who came to see us… We really enjoyed spending these 2 days with our neighbours from InEye-Pharma and ImmuneInsight: Read more…
Last week, it was a great pleasure to meet our partners during the kick-off meeting of ScaLABle-MEAT project, funded by EUREKA and the national funding agencies associated with the Eurostars program. It was held in the offices of Meatable (Delft). This ScaLaBlle-MEAT project is coordinated by Daan Luining (CTO and cofounder Read more…
Nathalie and Elodie will be present in Marseille for BioFit event next week! Indeed, HCS Pharma has a booth in Clubster NSL’s pavilion (number I20). Just stop by 🙂 It will be a pleasure to talk to you about the innovative 3D cell culture matrix BIOMIMESYS® and our related services Read more…